Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Michelle K White, Kristen L McCausland, Vaishali Sanchorawala, Spencer D Guthrie & Martha S Bayliss. (2017) Psychometric validation of the SF-36 Health Survey in light chain amyloidosis: results from community-based and clinic-based samples. Patient Related Outcome Measures 8, pages 157-167.
Read now
Read now
Huamao Mark Lin, Xin Gao, Catherine E. Cooke, Deborah Berg, Richard Labotka, Douglas V. Faller, Brian Seal & Parameswaran Hari. (2017) Disease burden of systemic light-chain amyloidosis: a systematic literature review. Current Medical Research and Opinion 33:6, pages 1017-1031.
Read now
Read now
Janet Shu, Stephen Lo, Margot Phillips, Fangui Sun, David C. Seldin, Isidore Berenbaum, John L. Berk & Vaishali Sanchorawala. (2016) Depression and anxiety in patients with AL amyloidosis as assessed by the SF-36 questionnaire: experience in 1226 patients. Amyloid 23:3, pages 188-193.
Read now
Read now
Martina Smorti, Francesco Cappelli, Silvia Guarnieri, Franco Bergesio & Federico Perfetto. (2014) Depression and cardiac symptoms among AL amyloidosis patients: the mediating role of coping strategies. Psychology, Health & Medicine 19:3, pages 263-272.
Read now
Read now
Articles from other publishers (6)
Lucia Ponti, Martina Smorti, Francesca Pozza, Alessia Argirò, Mattia Zampieri, Carlotta Mazzoni, Martina Gabriele, Carlo Di Mario, Iacopo Olivotto, Federico Perfetto & Francesco Cappelli. (2023) Anxious/Depressive Symptoms Alter the Subjective Perception of Heart Failure Severity in Transthyretin Cardiac Amyloidosis. The American Journal of Cardiology 192, pages 1-6.
Crossref
Crossref
Simone Bartolini, Samuele Baldasseroni, Francesco Fattirolli, Maria Vittoria Silverii, Lucrezia Piccioli, Federico Perfetto, Niccolò Marchionni, Carlo Di Mario, Raffaele Martone, Giulia Taborchi, Sofia Morini, Elisa Vignini & Francesco Cappelli. (2020) Poor right ventricular function is associated with impaired exercise capacity and ventilatory efficiency in transthyretin cardiac amyloid patients. Internal and Emergency Medicine 16:3, pages 653-660.
Crossref
Crossref
Baojian Liu, Ming Bai, Yan Wang, Di Wang, Jin Zhao, Lu Li, Ruijuan Dong & Shiren Sun. (2019) The efficacy and safety of bortezomib-based chemotherapy for immunoglobulin light chain amyloidosis: A systematic review and meta-analysis. European Journal of Internal Medicine 69, pages 32-41.
Crossref
Crossref
Michelle K. White, Martha S. Bayliss, Spencer D. Guthrie, Kimberly P. Raymond, Avery A. Rizio & Kristen L. McCausland. (2017) Content validation of the SF-36v2® health survey with AL amyloidosis patients. Journal of Patient-Reported Outcomes 1:1.
Crossref
Crossref
Martina Smorti, Silvia Guarnieri, Franco Bergesio, Federico Perfetto & Francesco Cappelli. (2015) Anxiety and depression among amyloid light-chain cardiac amyloidosis patients: The role of life satisfaction. European Journal of Cardiovascular Nursing 15:4, pages 269-275.
Crossref
Crossref
Francesco Cappelli, Samuele Baldasseroni, Franco Bergesio, Stefano Perlini, Francesco Salinaro, Luigi Padeletti, Paola Attanà, Alessandro Paoletti Perini, Alberto Moggi Pignone, Elisa Grifoni, Alessia Fabbri, Niccolò Marchionni, Gian Franco Gensini & Federico Perfetto. (2015) Echocardiographic and Biohumoral Characteristics in Patients With AL and TTR Amyloidosis at Diagnosis. Clinical Cardiology 38:2, pages 69-75.
Crossref
Crossref